Interferon alpha to be as adjuvant therapy for high risk melanoma

1997 ◽  
Vol 7 (Supplement 1) ◽  
pp. S23
Author(s):  
J Kirkwood
Keyword(s):  
High Risk ◽  
Adjuvant Therapy ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma

scholarly journals A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

2019 ◽  
Vol 68 (4) ◽  
pp. 619-629 ◽  
Author(s):  
Lorena P. Suarez-Kelly ◽  
Kala M. Levine ◽  
Thomas E. Olencki ◽  
Sara E. Martin del Campo ◽  
Elizabeth A. Streacker ◽  
...  
Keyword(s):  
Pilot Study ◽  
High Risk ◽  
Adjuvant Therapy ◽  
Dose Reduction ◽  
Interferon Alpha ◽  
Interferon Alpha 2B ◽  
High Risk Melanoma ◽  
Risk Melanoma

scholarly journals CN4 COST-EFFECTIVENESS (CE) ANALYSIS OF INTERFERON-ALPHA IN HIGH-RISK MELANOMA PATIENTS

2004 ◽  
Vol 7 (3) ◽  
pp. 221 ◽  
Author(s):  
M Ding ◽  
Y Xing ◽  
T Shih ◽  
D Cox ◽  
S Cantor ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Interferon Alpha ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients

scholarly journals Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)

2017 ◽  
Vol 23 (17) ◽  
pp. 5034-5043 ◽  
Author(s):  
Lisa H. Butterfield ◽  
Fengmin Zhao ◽  
Sandra Lee ◽  
Ahmad A. Tarhini ◽  
Kim A. Margolin ◽  
...  
Keyword(s):  
High Risk ◽  
Adjuvant Therapy ◽  
Randomized Trial ◽  
Peptide Vaccination ◽  
Gm Csf ◽  
Immune Correlates ◽  
High Risk Melanoma ◽  
Risk Melanoma

P14 Outcome of high risk melanoma patients treated with low dose interferon alpha 2B

1999 ◽  
Vol 9 (3) ◽  
pp. 328
Author(s):  
D. A. Vorobiof ◽  
D. E. Ostria ◽  
G. Vorobiof ◽  
M. R. Chasen
Keyword(s):  
High Risk ◽  
Interferon Alpha ◽  
Low Dose ◽  
Interferon Alpha 2B ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients
Sign in / Sign up

Export Citation Format

Share Document